Meridian Bioscience (VIVO) Tops Q2 EPS by 8c, Offers Guidance
Get Alerts VIVO Hot Sheet
Price: $33.97 --0%
Revenue Growth %: -100.0%
Financial Fact:
DILUTED EARNINGS PER COMMON SHARE: 0.13
Today's EPS Names:
NLY, CP, RUSHA, More
Revenue Growth %: -100.0%
Financial Fact:
DILUTED EARNINGS PER COMMON SHARE: 0.13
Today's EPS Names:
NLY, CP, RUSHA, More
Join SI Premium – FREE
Meridian Bioscience (NASDAQ: VIVO) reported Q2 EPS of $0.56, $0.08 better than the analyst estimate of $0.48. Revenue for the quarter came in at $85.3 million versus the consensus estimate of $84.5 million.
GUIDANCE:
Meridian Bioscience sees FY2021 EPS of $1.60-$1.80, versus the consensus of $1.66. Meridian Bioscience sees FY2021 revenue of $305-335 million, versus the consensus of $324 million.
For earnings history and earnings-related data on Meridian Bioscience (VIVO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Plexus Corp (PLXS) Tops Q2 EPS by 7c
- Methanex (MEOH) Tops Q1 EPS by 35c
- Northrim BanCorp (NRIM) Tops Q1 EPS by 54c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!